CompaniesLabcorp Clinical Trials

Labcorp Clinical Trials

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (11)
View all

Total Trials

11

As Lead Sponsor

0

As Collaborator

11

Total Enrollment

2,107

By Phase

NA: 1PHASE3: 2PHASE2: 5PHASE1: 1

By Status

COMPLETED: 5RECRUITING: 2UNKNOWN: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT02658253
NCT03069703
NCT03439943
NCT03873727
NCT03784014
NCT03947216
NCT05045261
NCT04166656
NCT05720910
Hover over trial bars to see details

Recent Trials

NCT06754553Collaborator
Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
N/ANot yet recruiting
100 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2026
NCT05720910Collaborator
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
NARecruiting
720 participants
Started: Oct 15, 2024 · Completed: Apr 30, 2027
NCT04166656Collaborator
Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.
PHASE3Recruiting
84 participants
Started: Sep 15, 2022 · Completed: Oct 31, 2028
NCT05045261Collaborator
ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation
PHASE2Unknown
100 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2024
NCT03947216Collaborator
Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
PHASE2Completed
117 participants
Started: Oct 23, 2020 · Completed: Jun 17, 2024
View all 11 trials →